Prevalence and Description of FIRE (Food Induced Immediate Response of the Esophagus) in the Pediatric Population With Eosinophilic Esophagitis
Launched by UNIVERSITY HOSPITAL, ANGERS · May 6, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a condition called Food Induced Immediate Response of the Esophagus, or FIRE, which is a newly recognized form of eosinophilic esophagitis. Eosinophilic esophagitis is an allergic condition that affects the esophagus, the tube that carries food from the mouth to the stomach. The trial aims to gather important information about how common FIRE is in children and teens, as well as to better understand its symptoms and how it can be diagnosed.
To participate in this study, children and teenagers between the ages of 6 and 17 who are being treated for eosinophilic esophagitis at Angers University Hospital may be eligible. However, those who have serious problems with communication or who don’t wish to take part in the study will not be included. Participants can expect to answer questions about their symptoms and experiences related to their condition, which will help researchers learn more about FIRE and improve diagnosis and treatment for others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over 6 and under 18 years of age at the time of inclusion
- • Follow-up in the allergology unit of Angers University Hospital for eosinophilic esophagitis
- Exclusion Criteria:
- • Patients or legal representative with severe communication or language comprehension difficulties
- • Patients or legal representatives objecting to study participation
About University Hospital, Angers
The University Hospital of Angers is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital leverages its multidisciplinary expertise and state-of-the-art facilities to investigate new therapeutic approaches and improve patient outcomes. Committed to excellence in patient care and medical education, the University Hospital of Angers collaborates with a network of researchers and healthcare professionals to facilitate groundbreaking studies across various medical fields, ensuring rigorous adherence to ethical standards and regulatory compliance. Through its clinical trial initiatives, the institution aims to contribute significantly to the advancement of medical knowledge and the development of effective treatments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Anne HOPPE
Principal Investigator
University Hospital of Angers
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported